Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 9 , ISSUE 1 ( January, 2005 ) > List of Articles

REVIEW ARTICLE

Recent trends in the management of status epilepticus

G. Rajshekher

Keywords : Status Epilepticus (SE), Refractory SE, Non-convulsive SE (NCSE), lorazepam, midazolam, barbiturate anesthesia

Citation Information : Rajshekher G. Recent trends in the management of status epilepticus. Indian J Crit Care Med 2005; 9 (1):52-63.

DOI: 10.4103/0972-5229.16271

License: CC BY-ND 3.0

Published Online: 01-01-2005

Copyright Statement:  Copyright © 2005; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Status Epilepticus (SE) is a neurologic emergency associated with high morbidity and mortality. The etiology varies among the different age groups, and it has a U-shaped incidence curve, being more common at the extremes of ages. Mortality is rarely due to the status itself, and the outcome depends to a great extent on the underlying etiology and the presence of additional medical conditions. Outcome also depends on the rapidity of diagnosis and initiation of appropriate therapy. Anti-epileptic drug administration in appropriate doses should begin promptly after the suspicion of SE; intra-muscular midazolam and rectal diazepam administered by paramedical staff involved in transporting the patient also has been shown to shorten the duration of SE. Attention should be paid in the initial stages itself to airway patency, adequacy of breathing and ventilation, the circulatory status, securing intravenous access and identifying the underlying cause. The goals of therapy include rapid termination of clinical and electrical ictal activity, prevention of aspiration pneumonia, and treatment of complications in anticipation. Every hospital needs to manage SE on the basis of established protocols, and an early decision regarding artificial ventilation and midazolam or barbiturate anesthesia for refractory SE needs to be taken. With the existing protocols and available drugs, it is generally possible to control seizures and prevent complications and mortality.


PDF Share
  1. Daniel H. Lowenstein MD, Brian K. Alldredge. Status Epilepticus. N Engl J Med 1998;338:970-6.
  2. Proposal for revised clinical and electroencephalographic classification of epileptic seizures: from the Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1981;22:489-501.
  3. Treatment of convulsive status epilepticus: Recommendations of the Epilepsy Foundation of America′s Working Group on Status Epilepticus. JAMA 1993;270:854-9.
  4. Shorvon S. Status epilepticus: Its clinical features and treatment in children and adults. Cambridge, England: Cambridge University Press; 1994.
  5. Bleck TP. Convulsive disorders: Status epilepticus. Clin Neuropharmacol 1991;14:191-8.
  6. Gastaut H, Broughton R. Epileptic seizures: Clinical and electrographic features, diagnosis and treatment. Springfield, Ill.: Charles CT; 1972. p. 25-90.
  7. Theodore WH, Porte RJ, Albert P, et al. The secondarily generalized tonic-clonic seizure: A videotape analysis Neurology 1994;44:1403-7.
  8. Simon RP, Aminoff MJ. Electrographic status epilepticus in fatal anoxic coma. Ann Neurol 1986;20:351-5.
  9. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992;42:100-4.
  10. Jordan KG. Continuous EEG ad evoked potential monitoring in the neuroscience intensive care unit. J Clin Neurophysiol 1993;10:445-75.
  11. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR, et al. Prevalence of non-convulsive status epilepticus in comatose patients. Neurology 2000;54:340.
  12. Litt B, Wityk RJ, Hertz SH, Mullen PD, Weiss H, Ryan DD, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998;39:1194-202.
  13. Brenner RP. Is it status? Epilepsia 2002;43:S103-13.
  14. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34:S37.
  15. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50:735-41.
  16. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-66.
  17. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004;11:800-10.
  18. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia; Neurology 1996;46:1029-35.
  19. Murthy JM, Yangala R. Acute symptomatic seizures - incidence and etiological spectrum: A hospital-based study from South India. Seizure 1999;8:162-5.
  20. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-66.
  21. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
  22. Vignatelli L, Tonon C, D′Alessandro R. Bologna Group for the Study of Status Epilepticus. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003;44:964-8.
  23. Singhi S, Singhi P, Dass R. Status epilepticus: Emergency management. Indian J Pediatr 2003;70:S17-22.
  24. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483-8.
  25. Hui AC, Joynt GM, Li H, Wong KS. Status epilepticus in Hong Kong Chinese: Etiology, outcome and predictors of death and morbidity. Seizure 2003;12:478-82.
  26. Kwong KL, Chang K, Lam SY. Features predicting adverse outcomes of status epilepticus in childhood. Hong Kong Med J 2004;10:156-9.
  27. Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Evans AC, Gjedde A, et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990;322:1781-7.
  28. Lothman EW, Bertram EH III, Stringer JL. Functional anatomy of hippocampal seizures. Prog Neurobiol 1991;37:1-82.
  29. Macdonald RL, Kapur J. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia 1999;40:S9-20; discussion S21-2.
  30. Kapur J, Macdonald RL. Rapid Seizure-Induced Reduction of Benzodiazepine and Zn2+ Sensitivity of Hippocampal Dentate Granule Cell GABAA Receptors. J Neurosciences 1997;17:7532-40.
  31. Simon RP. Physiologic consequences of status epilepticus. Epilepsia 1985;26:S58-66.
  32. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus Epilepsia 1993;34:S37-53.
  33. Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage: Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973;29:82-7.
  34. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates: Ischemic cell change and its relation to ictal physiological events. Arch Neurol 1973;28:10-7.
  35. Shorvon SD. Emergency treatment of status epilepticus. In: Shorvon SD, editor. Status epilepticus: Its clinical features and treatment in children and adults. Cambridge: Cambridge University Press; 1994. p. 175-292.
  36. Heafield MTE. Managing status epilepticus New drug offers real advantages. BMJ 2000;320:953-4.
  37. Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: Epidemiology, pathophysiology and management CNS. Drugs 2003;17:1013-30.
  38. Chin RFM, Neville BGR, Scott RC. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Child 2005;90:66-9.
  39. Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol 1988;101:267-75.
  40. Cock HR, Schapira AHV. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. Q J Med 2002;95:225-31.
  41. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling CA, Rowan J, et al. For The Veterans Affairs Status Epilepticus Cooperative Study Group. A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus. N Engl J Med 1998;339:792-8.
  42. Arendt RM, Greenblatt DJ, deJong RH, Bonin JD, Abernethy DR, Ehrenberg BL, et al. In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther 1983;227:98-106.
  43. Walton NY, Treiman DM. Lorazepam treatment of experimental status epilepticus in the rat: Relevance to clinical practice. Neurology 1990;40:990-4.
  44. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
  45. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America′s Working Group on Status Epilepticus. JAMA 1993;270.
  46. Nicol CF, Tutton JC, Smith BH. Parenteral diazepam in status epilepticus. Neurology 1969;19:332-43.
  47. George KA, Dundee JW. Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man. Br J Clin Pharmacol 1977;4:45-50.
  48. Osorio I, Reed RC. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia 1989;30:464-71.
  49. Wilder BJ. Efficacy of phenytoin in treatment of status epilepticus In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, editors. Advances in neurology Vol 34 Status epilepticus: Mechanisms of brain damage and treatment. New York: Raven Press; 1983. p. 441-6.
  50. Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin: Clinical and pharmacokinetic aspects. Neurology 1978;28:874-80.
  51. Browne TR. Fosphenytoin (Cerebyx) Clin Neuropharmacol 1997;20:1-12.
  52. Koul R, Deleu D. Subtherapeutic free phenytoin levels following fosphenytoin therapy in status epilepticus. Neurology 2002;58:147-8.
  53. Jamerson BD, Dukes GE, Brouwer KL, Donn KH, Messenheimer JA, Powell JR. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy 1994;14:47-52.
  54. Elson MA, Loewn GR, Voightman RE, Koup JR, Holmes GB, Hunt AJ, et al. Pharmacokinetics and tolerance of fosphenytoin and phenytoin administered intravenously to health subjects. Can J Neurol Sci 1993;20:S180.
  55. Ramsay RE, Philbrook B, Fischer JH, Sloan FB, Allen FH, Runge JW, et al. Safety and pharmacokinetics of fosphenytoin (Cerebyx) compared with Dilantin following rapid intravenous administration. Neurology 1996;46:A245.
  56. Ramsay RE, DeToldo J. Intravenous administration of fosphenytoin: Options for the management of seizures. Neurology 1996;46:S17-9.
  57. O′Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998;51:1034-9.
  58. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988;38:202-7.
  59. Goldberg MA, McIntyre HB. Barbiturates in the treatment of status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, editors. Advances in neurology Vol. 34 Status epilepticus: Mechanisms of brain damage and treatment. New York: Raven Press; 1983. p. 499-503.
  60. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;20:483-8.
  61. Bleck TP. Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955-7.
  62. Stecker MM, Kramer TH, Raps EC, O′Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
  63. Marik PE. Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004;10:3639-49.
  64. Angelini G, Ketzler JT, Coursin DB. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clin 2001;17:863-80.
  65. Stecker MM, Kramer TH, Raps EC, O′Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
  66. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: A study of 31 episodes. Epilepsia 2004;45:757-63.
  67. Stecker MM, Kramer TH, Raps EC, O′Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
  68. Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol in status epilepticus: Little evidence, many dangers? J Neurol 2003;250:1237-40.
  69. Ozdemir D, Gulez P, Uran N, Yendur G, Kavakli T, Aydin A. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure 2005;14:129-32.
  70. Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002;17:106-10.
  71. Jordan KG. Status epilepticus. A perspective from the neuroscience intensive care unit. Neurosurg Clin N Am 1994;5:671-86.
  72. Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993;43:895-900.
  73. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002;43:146-53.
  74. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005;64:353-5.
  75. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004;63:1507-8.
  76. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000;55:722-4.
  77. DeLorenzo RJ, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 2000;41:S40-4.
  78. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000;41:S17-20.
  79. Petroff OA, Hyder F, Rothman DL, Mattson RH. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543-8.
  80. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000;41:S10-6.
  81. Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999;837:263-9.
  82. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology 2003;60:332-4.
  83. Alexopoulos A, Lachhwani DK, Gupta A, Kotagal P, Harrison AM, Bingaman W, et al. Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis. Neurology 2005;64:567-70.
  84. Ma X, Liporace J, O′Connor MJ, Sperling MR. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res 2001;46:33-82.
  85. Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001;34:190-2.
  86. Hoppu K, Santavuori P. Diazepam rectal solution for home treatment of acute seizures in children. Acta Paediatr Scand 1981;70:369-72.
  87. Mitchell WG, Shellenberger K, Groves L, et al. Rectal diazepam gel (Diastat) for acute repetitive seizures: Results of a double-blind, placebo-controlled study in children and adults with epilepsy. Epilepsia 1996;37:154.
  88. Bell DM, Richards G, Dhillon S, Oxley JR, Cromarty J, Sander JW, et al. A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsy Res 1991;10:183-90.
  89. Lahat E, Aladjem M, Eshel G, Bistritzer T, Katz Y. Midazolam in treatment of epileptic seizures. Pediatr Neurol 1992;8:215-6.
  90. Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol 1995;12:213-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.